Allergan Korea Aesthetic-AbbVie Company said it has selected Kim Sook-hyun as the new CEO as of Jan. 1

She is a global healthcare professional with 22 years of experience in Korea, Asia, and headquarters receiving an MBA at Kelley School of Business after graduating from industrial pharmacy at Seoul National University.

She joined Abbott Korea in 2006, as the Humira Business Unit Manager and served as the director of Commercial Business Divisions in Japan and Asia Pacific in Singapore in 2011. In 2015, she took over the head of the Immunization Division at AbbVie, Korea.

Since 2018, she has been contributing to the establishment of immune drug brand strategy and organizati